[1] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
[2] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
[3] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[4] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
[5] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
[6] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
[7] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
[8] |
Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin.
Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma
[J]. Journal of International Oncology, 2023, 50(2): 117-121.
|
[9] |
Zhao Jianhao, Duan Yanchao.
Research progress in the pathogenesis of extramedullary disease in multiple myeloma
[J]. Journal of International Oncology, 2023, 50(1): 55-59.
|
[10] |
Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou.
Advances in immunotherapy for recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2022, 49(9): 517-520.
|
[11] |
Peng Chen, Xie Yintong, Zhang Xin, Xie Peng.
Research progress of maintenance therapy for cervical cancer
[J]. Journal of International Oncology, 2022, 49(7): 430-435.
|
[12] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
[13] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
[14] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
[15] |
Xu Kai, Wen Gang, Li Rui, Tian Yuan.
Research progress on the prognostic value of the ratio of lymphocytes to C-reactive protein in digestive system neoplasms
[J]. Journal of International Oncology, 2022, 49(10): 627-629.
|